Purpose : Purpose of this study was to determine if quantitative measures of CT attenuation and ADC values in combination with conventional imaging features can differentiate primary central nervous system lymphoma (PCNSL) and glioblastoma (GBM).
INTRODUCTION
www.ksmrm.org JKSMRM 16(3) : [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] 2012 radiation therapy is the mainstay in treatment for PCNSL (3, 4) . Thus, radical surgical resection is not indicated for presumable PCNSL because only a brain biopsy is needed to make a pathologic diagnosis (5) .
Glioblastomas (GBMs) are the most common malignant tumors in adults and are also showing an increasing trend due to population aging. Although, the prognosis of GBMs has been much improved by the recent development of the DNA alkylating agent temozolamide (6) , wide surgical resection is the key to prolonged survival and prognosis for GBM (7, 8) .
In immunocompetent patients, PCNSL lesions are isoattenuated or hyperattenuated on unenhanced CT images and show marked contrast enhancement on both CT and MR images (9) (10) (11) . However, these findings are nonspecific and are also observed for GBM. Although perfusion-weighted imaging (PWI) may aid the differentiation of PCNSL and GBM by demonstrating a low cerebral blood volume in PCNSL (11, 12) , this imaging method has several disadvantages, such as, relatively low resolution, sensitivity to magnetic susceptibility artifacts, and the use of gadolinium contrast agent (2, 13) .
Diffusion-weighted imaging (DWI) is not only one of the advanced imaging methods but also is a straightforward and easily applied method in clinical practice, unlike PWI or MR spectroscopy. DWI measures the diffusion property of water molecules within biologic tissues, and thus, intratumoral apparent diffusion coefficients (ADCs) are considered imaging markers of cellularity for various tumors (14) . Furthermore, some authors have found that PCNSL lesions have lower ADC values than GBM lesions (15, 16) .
Because CT attenuation is directly proportional to electron density of the tissue and the atomic number of the tissue composition in a given volume, CT attenuation is correlated with tumor cellularity (17) , and can be used as an imaging marker for tumor cellularity. However, to the best of our knowledge, there has been no study on quantitative analysis on PCNSL and GBM, except one having briefly addressed the quantification of CT attenuation of GBM and PCNSL on a table (18) . Unfortunately, the authors did not discuss the CT attenuations of the two tumors groups in detail because differentiation between PCNSL and GBM were not their subject (18) . Nevertheless, the attenuations of lesions on unenhanced CT could provide attractive markers, in terms of, simplicity, cost-effectiveness, and feasibility, if they could be used to differentiate PCNSL and GBM accurately.
We hypothesized that unlike heterogeneous, loosely packed GBMs, homogeneous densely packed PCNSLs would have higher attenuations on unenhanced CT images and lower ADC values on DW images. In addition we hypothesized that conventional imaging features can differentiate PCNSL and GBM, and that quantitative analysis of CT attenuation and ADC values help distinguish PCNSL from GBM in case of PCNSL having uncommon conventional features, such as PCNSL with necrosis. Hence, the purpose of this study was to determine whether quantitative measures of CT attenuation and ADC, in combination with conventional imaging features, can differentiate PCNSL and GBM.
This retrospective study was approved by the institutional review boards of the hospitals involved; the requirement for informed consent was waived.
Patients
Twenty consecutive patients with pathologically proven PCNSL were recruited between March 2006 and December 2010 at two university-affiliated institutions. Those patients that had undergone both unenhanced CT and conventional magnetic resonance (MR) imaging with DWI before surgery or surgical biopsy were considered. Two of the 26 without initial unenhanced CT images, and 6 without DW images were excluded. Finally 14 patients with PCNSL (11 men and 3 women; median age, 61 years; age range, 41 -74 years; 13 diffuse large B cell lymphoma, 1 extranodal NK/T-cell lymphoma, nasal type) were included in the study.
For comparison purposes, 32 patients with pathologically proven GBM that enrolled at one of the institutions between March 2006 and December 2009 were also considered. Four patients without an initial unenhanced CT images and two without DW images were excluded. Thus, 26 patients with GBM (14 men and 12 women; median age, 50 years; age range, 22 -73 years) were finally included for analysis.
MATERIALS AND METHODS
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CT imaging
All CT scans were obtained using a helical CT scanner (LightSpeed, GE Medical Systems, Milwaukee, WI; or a Definition, Siemens Medical Systems, Erlangen, Germany). The scanning parameters for unenhanced CT were 120 kVp and 330 mAs with an image matrix of 512 × 512, a 23-or 24-cm field of view, and a section thickness of 5-mm.
Conventional MRI and diffusion weighted MR imaging
MR examinations were conducted using a 1.5T unit (Intera, Philips Medical Systems, Best, the Netherlands) (5 patients with PCNSL) or a 3T unit (SignaHDxt, GE Medical Systems, Milwaukee, WI, USA) (9 patients with PCNSL and all 26 patients with GBM).
MRI examinations included the following sequences: axial T1-weighted spin-echo (TR/TE, 500/8-15 ms; Diffusion-weighted imaging data at 1.5T were obtained by applying three orthogonal diffusion gradients at following parameters: TR/TE, 11000-12000/15-30; FOV, 22-24 cm; ST/IG, 3.5 mm/0 mm; matrix, 128×128, b value, 1000 sec/mm 2 ). Diffusion maps at 3T were obtained from diffusion tensor imaging data set. Diffusion tensor imaging data at 3T were obtained by applying orthogonal diffusion gradients in six different directions and b value of 0 and 1000 s/mm -2 (TR/TE, 10000/92.4 ms; FOV, 24 cm; ST/IG, 3.5 mm/0 mm; matrix, 128×128). ADC maps were generated from these imaging data.
Image Analysis
CT and ADC map analyses were performed in a blinded manner by one experienced neuroradiologist on a picture archiving and communication system (Centricity, GE Medical System, Milwaukee, WI, USA).
To exclude regions with hemorrhage or typical vasogenic edema, unenhanced T2-weighted and postcontrast T1-weighted MR images were crosschecked. When there are multiple tumors, the largest one was selected for quantitative measurement. In each patient, 6 regions of interest (at least over 20 mm 2 ) were defined and measured the area of ADC map that corresponded to the solid enhancing portion on postcontrast T1-weighted MR images. The lowest minimum ADC value from among these measurements was selected for statistical analysis. Minimum ADC values of same sized regions in contralateral homologous normal appearing brain parenchyma were measured to calculate ADC ratios.
The highest maximum CT attenuationsin the solid tumor portions were also measured. Regions of necrosis, hemorrhage, or typical vasogenic edema were carefully excluded by examining T2-weighted and postcontrast T1-weighted MR images. CT and MR images were not coregistered. However, the rater carefully compared each pair of CT and MR images to minimize possible errors due to differences in the slice position and scan angle by referring to anatomical landmarks.
Also author compared maximum CT density, minimum ADC and minimum ADC ratio between necrotic PCNSLs (n = 4) and necrotic GBMs (n = 24).
Two radiologists, unaware of final diagnoses and with 12 and 5 years of experience, reviewed all CT and MR images by consensus. They assessed the following imaging features for each tumor: enhancing tumor margin (well defined versus ill defined), tumor enhancement (homogeneous versus heterogeneous), the presence of necrosis, the presence of ventricular wall involvement, the presence of cortical surface involvement, and multiplicity (multiple versus solitary).
Statistical Analysis
Statistical analysis was performed using commercially available software (PASW Statistics version 17.0; SPSS, Chicago, Ill). Before performing individual analysis, the distributions of data setswere checked for normality. The Mann-Whitney test was used to compare quantitative parameters (maximum CT attenuations, minimum ADC values, and minimum ADC ratios) in the GBM and PCNSL patient groups. The ADC and ADC ratio cutoff value for the differentiation of GBM and PCNSL was determined by receiver operating characteristic (ROC) curve analysis, and areas under the curves (AUCs) were calculated as indices of overall diagnostic accuracy.
Fisher's exact test was used to compare conventional MRI findings in the two groups. Differences were considered significant when P values were < 0.05.
Mean maximum CT attenuation were similar in the PCNSL and GBM groups (mean ± SD; 37.84 ± 6.90 HU versus 37.00 ± 5.54 HU, p = 0.68) (Fig. 1) (Fig. 2) .
ROC analysis revealed that the optimal ADC ratio cutoff value for differentiating PCNSL from GBM was 1.006 (sensitivity 85.7%; specificity 69.2%; AUC = (Figs. 4-7) .
RESULTS

Differentitation between
Even in a subset of necrotic tumors, mean minimum ADC and ADC ratios were significant different between PCNSL (n = 4) and GBM (n = 24) with lower minimum ADC/ADC ratio for PCNSL (Table 3) .
In this study, the CT attenuations of PCNSL and GBM tumors were similar, but minimum ADC and minimum ADC ratio values were significantly lower for PCNSL tumors. In addition, the PCNSL-favoring imaging features identified were greater homogeneous enhancement, less frequent necrosis, and tumor multiplicity. Unlike MRI, which provides information on the chemical composition of tissues, CT provides information on tissue electron density differences in the form of Hounsfield Units (HUs). Therefore, CT is highly sensitive to small calcifications and hemorrhages, which contain either high atomic number elements or electron dense materials, such as, iron-containing hemoglobin (19) . It has also been suggested that high attenuation within a tumor may be due high packing density of abnormal cells (20) . Several previous reports demonstrated that PCNSL tumors are iso-or hyper-attenuated on unenhanced CT images (9-11). However, no previous comparative study has addressed CT attenuation in PCNSL and GBM tumors. Due to recent advances in high-resolution multidetector CT, we considered that quantitative measures of CT attenuation might facilitate the characterization of tumors more cost-effectively than advanced MRI techniques. However, this study shows our hypothesis that CT attenuation measurements might enable the differentiation of PCNSL and GBM was found to be false, which suggests that factors other than tumor cellularity determine tumor CT attenuation values.This result may have been caused by the poor discriminative ability of CT itself, or because maximum CT attenuation was used in the quantitative analysis. We presumed that maximum CT attenuation would better represent the most compactly packed tumor regions than mean CT attenuation, and this may have narrowed the difference between the two groups. We speculate that more elaborative approach such as histogram analysis would provide further information from CT in the future study.
In the present study, mean minimum ADC and minimum ADC ratio were lower in PCNSL than in GBM. In this study, we used minimum ADC values instead of mean ADC because we assumed that minimum ADC would represent the most compact cellular area in the tumor and accordingly better differentiate GBM and PCNSL in terms of cellularity difference (16) . In a study by Guo et al., mean ADC of CNS lymphomaswas found to be 870 ± 270 × 10 -6 mm 2 /s, and the mean ADC of high grade gliomas was 1210 ± Differentitation between Primary Central Nervous System Lymphoma and Glioblastoma � Seung Choul Lee, et al. In the present study, minimum ADC ratio was found to be significantly lower in PCNSL than in GBM with a p value of 0.007, and in previous studies, ADC ratios for PCNSL were also found to be lower than those of GBM (0.63 -1.15 versus 1.26 -1.68) (16, 21, 22) . In contrast to ADC, which provides a measure of water molecule diffusion in a given voxel, ADC ratio is insensitive to systemic noise or variability (23), and we speculate that this insensitivity caused ADC ratio to better differentiate PCNSL and GBM.
ROC curve analysis showed that a minimum ADC ratio cutoff of 1.006 had a sensitivity of 85.7% for the differentiation of PCNSL and GBM. A previous study on 10 PCNSL and 10 GBM patients found 100% sensitivity and specificity for an ADC ratio cutoff of 1.06 (16) . We speculate that the larger number of patients enrolled in the present study might have been responsible for this lower diagnostic accuracy. Combined approach (encompassing DWI, PWI, and MR spectroscopy) rather than single parameter approach is perhaps needed for the differentiation of these two disease entities.
With regard to conventional imaging features, PCNSL tumors were found to more frequently exhibit homogeneous enhancement and to be less prone to necrosis, which agrees well with previous studies (24) (25) (26) .
Interestingly, we found that tumor involvement sites were similar in the two groups. PCNSL tumors are commonly located at subependymal regions abutting (27) . In one study of 103 focal Non-AIDS PCNSL tumors, 56% were found to abut the lateral ventricular wall (24) . Although ventricular wall involvement was not focused on in older studies, a recent study reported that 93% of gliomas contacted at least one region of the lateral ventricular wall (28), whereas another report found that 47% of GBMs involved the lateral ventricular wall (29) . In the present study, ventricular wall involvement was observed for 46% of GBMs and 64% of PCNSLs, which suggests that periventricular involvement is not a distinguishing feature for PCNSL. Likewise, other site involvements, such as, of deep gray matter and superficial cortex, were not found to be helpfully differentiating GBM and PCNSL.
In addition, we found that multiplicity was significantly more frequent in PCNSL (35.7%) than in GBM (7.7%). Upto 40% of PCNSL cases reportedly harbor multiple lesions (10, 24, 25, 30, 31) . In a recent study, it was reported some GBMs develop from neural stem cells regions and that this process results in the formation of multiple tumors (29) . Nevertheless, multiplicity at presentation has been reported to be less frequent in GBM than in PCNSL (10, 24) , and the present study shows the same result.
Based on our results, we speculate that irrespective of tumor involvement site, a non-necrotic homogeneously enhanced tumor with a low minimum ADC ratio on DW images is suggestive of PCNSL rather than GBM, and that tumor multiplicity increases the likelihood of PCNSL.
Moreover, even in a subset of necrotic tumors, we found lower minimum ADC and minimum ADC ratio in necrotic PCNSL as compared to necrotic GBM. When we encounter a necrotic enhancing mass on MR imaging, differential diagnosis of this mass could be easier by providing quantitative analysis of minimum ADC and minimum ADC ratio.
Several limitations of the present study bear consideration. First, it is intrinsically limited by its retrospective design. In particular, some PCNSL and GBM patients were not enrolled because they did not undergo imaging, which may have caused selection bias. Second, CT attenuation was measured without co-registering CT and MR images, although the rater made measurements carefully to minimize possible errors. Third, ADC value determinations reportedly show high inter-observer variability, and thus, we also calculated ADC ratios, which according to Sasaki et al.(23) , are more suitable for assessing diffusion abnormalities in multicenter studies. Finally, the small number of patients undoubtedly affected the accuracy of the ROC curve analysis.
In conclusion, this study shows that CT attenuation values determined on unenhanced CT images do not aid the differentiation of PCNSL and GBM. Nevertheless, we suggest that the minimum ADC and minimum ADC ratios and the presence of homogeneous enhancement, necrosis, and multiplicity aid the differentiation PCNSL and GBM.
